# Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome

> **NCT04216797** · PHASE4 · WITHDRAWN · sponsor: **Swedish Medical Center**

## Conditions studied

- Levator Ani Syndrome

## Interventions

- **DRUG:** Diazepam Tablets

## Key facts

- **NCT ID:** NCT04216797
- **Lead sponsor:** Swedish Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01-09
- **Primary completion:** 2023-02-21
- **Final completion:** 2023-02-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Enrollment was initially suspended due to COVID pandemic. As the number of cases subsided, enrollment was reopened but never regained momentum. PI has left the site.
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04216797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04216797, "Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04216797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*